{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=removal+from+study&page=7", "query": { "intervention": "removal from study", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 637, "total_pages": 64, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=removal+from+study&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=removal+from+study&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T17:53:14.388Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04478279", "title": "A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glioblastoma", "Melanoma Stage IV", "Breast Cancer", "Prostate Cancer", "Glioblastoma Multiforme", "GBM", "Brain Cancer", "Metastatic Breast Cancer", "Metastatic Melanoma", "Metastatic Prostate Cancer", "Melanoma Recurrent", "Prostate Cancer Metastatic", "Recurrent Glioblastoma", "Newly Diagnosed Glioblastoma" ], "interventions": [ { "name": "ST101", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Sapience Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2020-07-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-02-09", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 7, "location_summary": "San Francisco, California • Denver, Colorado • Warrenville, Illinois + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Warrenville", "state": "Illinois" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04478279" }, { "nct_id": "NCT05810194", "title": "Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Radiation Dermatitis" ], "interventions": [ { "name": "StrataXRT", "type": "DEVICE" }, { "name": "Calendula", "type": "DRUG" }, { "name": "Aquaphor", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Stratpharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2023-05-01", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2024-02-01", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05810194" }, { "nct_id": "NCT05145595", "title": "Pain Sensitivity During Puberty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Thermal Sensory Analyzer", "type": "DEVICE" }, { "name": "Pressure Stimuli", "type": "DEVICE" }, { "name": "Mechanical Stimuli", "type": "DEVICE" }, { "name": "Pain Ratings", "type": "BEHAVIORAL" }, { "name": "Thermal pain thresholds", "type": "BEHAVIORAL" }, { "name": "Pressure pain thresholds (PPT)", "type": "BEHAVIORAL" }, { "name": "Mechanical temporal summation", "type": "BEHAVIORAL" }, { "name": "Conditioned pain modulation (CPM) efficiency", "type": "BEHAVIORAL" }, { "name": "Offset analgesia efficiency", "type": "BEHAVIORAL" }, { "name": "Cold pain tolerance", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "9 Years to 16 Years" }, "enrollment_count": 36, "start_date": "2022-09-20", "completion_date": "2024-07-17", "has_results": false, "last_update_posted_date": "2026-01-09", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05145595" }, { "nct_id": "NCT01374672", "title": "Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Localized Osteosarcoma", "Metastatic Osteosarcoma", "Osteoblastic Osteosarcoma", "Recurrent Osteosarcoma" ], "interventions": [ { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "10 Years to 20 Years" }, "enrollment_count": 20, "start_date": "2011-07", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01374672" }, { "nct_id": "NCT04163614", "title": "Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease", "Hypertension", "Extracellular Volume Overload", "Intradialytic Hypotension" ], "interventions": [ { "name": "IBPS-Guided Ultrafiltration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2021-02-10", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04163614" }, { "nct_id": "NCT00002611", "title": "Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney Cancer" ], "interventions": [ { "name": "dactinomycin", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "0 Years to 15 Years" }, "enrollment_count": 3031, "start_date": "1995-07", "completion_date": "2003-08", "has_results": false, "last_update_posted_date": "2021-02-25", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 206, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 151 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002611" }, { "nct_id": "NCT03136471", "title": "Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes Mellitus, Type 2", "Chronic Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Tulane University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22242, "start_date": "2017-01", "completion_date": "2021-03-01", "has_results": false, "last_update_posted_date": "2023-03-21", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03136471" }, { "nct_id": "NCT01583465", "title": "Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis, Hip", "Joint Deformities, Acquired", "Hip Dislocation, Congenital", "Osteonecrosis", "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Aquamantys", "type": "DEVICE" }, { "name": "standard electrocautery (Bovie)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Joint Implant Surgeons, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2009-10", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2012-04-24", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "New Albany, Ohio", "locations": [ { "city": "New Albany", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01583465" }, { "nct_id": "NCT04517838", "title": "Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Adenocarcinoma", "HER2-Positive Breast Carcinoma", "Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 230, "start_date": "2020-07-31", "completion_date": "2028-07-27", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04517838" }, { "nct_id": "NCT07288203", "title": "A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma (Skin Cancer)", "Unresectable Melanoma", "Metastatic Melanoma" ], "interventions": [ { "name": "Lifileucel", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Iovance Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 24, "start_date": "2025-11-28", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-28T17:53:14.388Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07288203" } ] }